EARLIER CANCER DETECTION.
- Dec 19, 2017
Clinical Genomics Pathology Inc. Receives Accreditation from College of American Pathologists (CAP) for Liquid Biopsy Lab
- Dec 12, 2017
Roy Davis joins liquid biopsy company Clinical Genomics board of directors
- Nov 30, 2017
Clinical Genomics receives CSIRO award for Entrepreneurship in Science.
Clinical Genomics develops innovative products for colorectal cancer diagnosis. Our passion is to introduce advanced healthcare solutions to address unmet needs. With a broad intellectual property portfolio including more than 95 patents, Clinical Genomics delivers products to improve early cancer detection and cancer recurrence monitoring.
CLINICAL GENOMICS HAS DEVELOPED COLVERA, A GENOMIC BLOOD TEST TO DIAGNOSE COLORECTAL CANCER RECURRENCE AT THE EARLIEST, MOST TREATABLE STAGES.
Clinical Genomics is investing in technologies and clinical research that deliver better options to healthcare practitioners and lead to improved clinical outcomes for patients.